Patent · US Active

Pharmaceutically acceptable salts of fatty acids

US10017453B2 · kind B2 · utility

0Cited by

6References

5Claims

0Family size

Assignee

DS Biopharma Limited · IE

Inventors

Mehar Manku · Birmingham, GB
David Coughlan · Dublin, IE
Bill Downes · Dublin, IE

Key dates

Filing date	Nov 17, 2014
Grant date	Jul 10, 2018
Priority date	—
Expiry date	Nov 17, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C241/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides pharmaceutically acceptable stable salt forms of 15-lipoxygenase products, such as 15-HETrE lysine salt, compositions comprising same and methods of making and using same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.